Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Sarepta Therapeutics Inc

+ Add to Watchlist

AB3A:GR

11.879 EUR 0.119 1.01%

As of 10:30:35 ET on 03/04/2015.

Snapshot for Sarepta Therapeutics Inc (AB3A)

Open: 11.806 Day's Range: 11.796 - 12.110 Volume: 0
Previous Close: 11.760 52wk Range: 9.621 - 28.439 1-Yr Rtn: -42.39%

Stock Chart for AB3A

No chart data available.
  • AB3A:GR 12.110
  • 1D
  • 1M
  • 1Y
11.760
Interactive AB3A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AB3A

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -4.3770
Est. PEG Ratio -
Market Cap (M EUR) 488.67
Shares Outstanding (M) 41.31
30 Day Average Volume 275
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AB3A

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AB3A

Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of unique RNA-based therapeutics for the treatment of both rare and infectious diseases. The Company offers its products to the medical industry in countries around the world.

Christopher N GarabedianPresident/CEOSandesh Mahatme "Sandy"Senior VP/CFO/Chief Acctg Ofcr
Edward M KayeSenior VP/Chief Medical OfficerDavid Tyronne Howton "Ty"Senior VP/Secretary/Gen Counsel
More Company Profile & Key Executives for AB3A

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil